SG Americas Securities, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,514,000
+285.2%
40,890
+97.8%
0.02%
+375.0%
Q2 2022$393,000
-86.1%
20,672
-80.3%
0.00%
-81.0%
Q1 2022$2,829,000
-18.7%
104,817
-32.1%
0.02%
+10.5%
Q4 2021$3,480,000
+1855.1%
154,450
+2172.3%
0.02%
+1800.0%
Q3 2021$178,000
-67.4%
6,797
-60.1%
0.00%
-66.7%
Q4 2020$546,000
-76.6%
17,034
-72.5%
0.00%
-80.0%
Q3 2020$2,331,000
+579.6%
61,953
+707.5%
0.02%
+400.0%
Q2 2020$343,0007,6720.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders